Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Ambarella is the name drawing the most attention in options markets today. Traders circulated an unconfirmed M&A rumour suggesting the chip designer is seeing takeover interest. The stock carries a short interest of 12.2% of free float. With availability sitting at 417%, there is ample borrow for short sellers who doubt the story.
The broader chip complex is also generating heavy call flow. NVIDIA and Micron Technology top the ORTEX screen for positive options bets over the past week. Both sit in semiconductors, an industry where Japan's machine tool orders just printed 63% above year-ago levels, according to ORTEX Alt Data. That kind of industrial momentum tends to feed demand for leading-edge chips.
Big bank earnings are arriving this week, with Bank of America, and several others reporting Q3 results. has an RSI of 40.9, placing it in mild oversold territory. Options traders appear cautious: the insurer's Q3 call precedes results that could move the managed-care sector sharply.
Clover Health popped on heavy volume today without an obvious catalyst. The stock is up 95% year to date. Short sellers have 4.7 days to cover. A sudden price spike with that kind of short base can force rapid position unwinds, amplifying moves that options markets then price aggressively.
Sentiment across the market is mixed. Chip names dominate the bullish options bets table. Defensive and health-care names carry more cautious positioning ahead of earnings.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
